Bahl & Gaynor’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $345K | Hold |
1,252
| – | – | ﹤0.01% | 309 |
|
|
2026
Q1 | $334K | Hold |
1,252
| – | – | ﹤0.01% | 298 |
|
|
2025
Q4 | $345K | Buy |
1,252
+4
| +0.3% | +$1.12K | ﹤0.01% | 301 |
|
|
2025
Q3 | $360K | Hold |
1,248
| – | – | ﹤0.01% | 299 |
|
|
2025
Q2 | $413K | Hold |
1,248
| – | – | ﹤0.01% | 296 |
|
|
2025
Q1 | $411K | Sell |
1,248
-28
| -2% | -$8.44K | ﹤0.01% | 295 |
|
|
2024
Q4 | $352K | Hold |
1,276
| – | – | ﹤0.01% | 302 |
|
|
2024
Q3 | $442K | Sell |
1,276
-4
| -0.3% | -$1.38K | ﹤0.01% | 292 |
|
|
2024
Q2 | $423K | Sell |
1,280
-150
| -10% | -$51.7K | ﹤0.01% | 294 |
|
|
2024
Q1 | $519K | Sell |
1,430
-109
| -7% | -$35.9K | ﹤0.01% | 283 |
|
|
2023
Q4 | $461K | Sell |
1,539
-14
| -0.9% | -$4.09K | ﹤0.01% | 286 |
|
|
2023
Q3 | $444K | Buy |
1,553
+6
| +0.4% | +$1.71K | ﹤0.01% | 281 |
|
|
2023
Q2 | $434K | Sell |
1,547
-2
| -0.1% | -$521 | ﹤0.01% | 292 |
|
|
2023
Q1 | $396K | Sell |
1,549
-159
| -9% | -$46.3K | ﹤0.01% | 296 |
|
|
2022
Q4 | $566K | Sell |
1,708
-80
| -4% | -$25.3K | ﹤0.01% | 273 |
|
|
2022
Q3 | $496K | Hold |
1,788
| – | – | ﹤0.01% | 274 |
|
|
2022
Q2 | $471K | Buy |
1,788
+42
| +2% | +$10.8K | ﹤0.01% | 283 |
|
|
2022
Q1 | $418K | Buy |
1,746
+180
| +11% | +$42.1K | ﹤0.01% | 294 |
|
|
2021
Q4 | $360K | Hold |
1,566
| – | – | ﹤0.01% | 301 |
|
|
2021
Q3 | $313K | Hold |
1,566
| – | – | ﹤0.01% | 308 |
|
|
2021
Q2 | $371K | Hold |
1,566
| – | – | ﹤0.01% | 305 |
|
|
2021
Q1 | $379K | Buy |
1,566
+9
| +0.6% | +$2.01K | ﹤0.01% | 306 |
|
|
2020
Q4 | $324K | Sell |
1,557
-157
| -9% | -$30.8K | ﹤0.01% | 304 |
|
|
2020
Q3 | $290K | Hold |
1,714
| – | – | ﹤0.01% | 303 |
|
|
2020
Q2 | $322K | Sell |
1,714
-331
| -16% | -$62.8K | ﹤0.01% | 303 |
|
|
2020
Q1 | $362K | Sell |
2,045
-75
| -4% | -$14.5K | ﹤0.01% | 300 |
|
|
2019
Q4 | $434K | Sell |
2,120
-316
| -13% | -$57.9K | ﹤0.01% | 310 |
|
|
2019
Q3 | $370K | Sell |
2,436
-683
| -22% | -$111K | ﹤0.01% | 318 |
|
|
2019
Q2 | $491K | Sell |
3,119
-94
| -3% | -$14.7K | ﹤0.01% | 305 |
|
|
2019
Q1 | $517K | Hold |
3,213
| – | – | ﹤0.01% | 298 |
|
|
2018
Q4 | $610K | Buy |
+3,213
| New | +$670K | 0.01% | 284 |
|
Other funds holding CI
Bahl & Gaynor's CI Position: Q2 2026 in Review
Bahl & Gaynor held its Cigna (CI) position steady in Q2 2026 at 1,252 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #309.
Bahl & Gaynor first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $610K in Q4 2018. 1,701 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Bahl & Gaynor held 1,252 shares of Cigna worth $345K as of Q2 2026.
- Bahl & Gaynor left its Cigna share count unchanged in Q2 2026.
- Cigna made up ﹤0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #309 holding.
- Bahl & Gaynor first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- Bahl & Gaynor's Cigna position peaked at $610K in Q4 2018.
- 1,701 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.